Boothbay Fund Management, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$2.55 - $4.42 $22,363 - $38,763
-8,770 Reduced 31.47%
19,098 $84,000
Q2 2022

Aug 15, 2022
SELL
$2.71 - $3.6 $3,571 - $4,744
-1,318 Reduced 4.52%
27,868 $77,000
Q3 2021

Nov 15, 2021
SELL
$3.14 - $4.09 $11,461 - $14,928
-3,650 Reduced 11.12%
29,186 $96,000
Q1 2021

May 17, 2021
BUY
$3.46 - $7.88 $113,612 - $258,747
32,836 New
32,836 $126,000

Others Institutions Holding BCLI

# of Institutions
41
Shares Held
10.8M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $83.2M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email